Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
CCX354, GSK2941266
Also known as: CCR1 antagonist
print preview
bookmark
share with colleague
General Information
Company
ChemoCentryx Inc.
Description
Small molecule CC chemokine receptor 1 (CCR1) antagonist
Molecular Target
CC chemokine receptor 1 (CCR1) (CD191)
Mechanism of Action
CC chemokine receptor 1 (CCR1) antagonist
Latest Stage of Development
Phase II
Indication
Rheumatoid arthritis (RA)
Partner
GlaxoSmithKline plc
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy